在中国人口中,MEF2家族基因多态化与对多发性硬化症的易感性之间存在关联
Lei Wu1, Bo Liu2, Yanbing Wei3
1Department of Neurology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310000, China.
Acta neurologica Belgica
|August 12, 2023
概括
MEF2D基因的遗传变异,特别是rs2274316和rs3790455,与患多发性硬化症 (MS) 的风险增加有关. 在MS患者中,MEF2D基因表达也更高,这表明它在疾病易感性方面的作用.
科学领域:
- 免疫遗传学 免疫遗传学
- 神经免疫学 神经免疫学
- 分子生物学分子生物学
背景情况:
- 多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
- 肌细胞增强因子2 (MEF2) 基因家族与免疫反应有关.
- 了解导致MS易感性的遗传因素对于开发向疗法至关重要.
研究的目的:
- 调查MEF2D和MEF2C基因中的多态化与患MS的风险之间的关联.
- 评估MEF2D基因表达水平与MS之间的相关性.
- 确定中国人群中MS的潜在遗传风险因素.
主要方法:
- 病例控制研究涉及174名多发性硬化患者和120名健康对照.
- 聚合酶连锁反应-限制片段长度多态化 (PCR-RFLP) 用于基因型定制MEF2D和MEF2C.
- 定量实时PCR (qRT-PCR) 用于测量外围血液白细胞中MEF2D转录水平.
主要成果:
- 在MS和MEF2D中rs2274316的C等位基因/CC基因型,以及rs3790455.5的C等位基因/CT基因型之间发现了显著的关联.
- 在MS患者的白细胞中,MEF2D显著过度表达,特别是在具有CC基因型rs2274316.6的患者中.
- 没有观察到这些多态度与发病年龄或MS表型之间的相关性.
结论:
- 在中国人群中,MEF2D基因多态 rs2274316和rs3790455是MS的潜在遗传风险因素.
- 较高的MEF2D转录水平与MS易感性和MEF2D基因多态性有关.
- 这些发现突显了MEF2D在多发性硬化症的发病过程中的作用.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K


